🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, alleging the companies hid potential risks that the medication presented to pediatric neurological development.

This legal action comes thirty days after Former President Trump promoted an unverified association between using Tylenol - also known as acetaminophen - throughout gestation and autism in offspring.

Paxton is filing suit against J&J, which formerly manufactured the medication, the exclusive pain medication approved for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he claimed they "misled consumers by profiting off of pain and pushing pills regardless of the potential hazards."

The company asserts there is lacking scientific proof linking Tylenol to autism.

"These manufacturers misled for generations, deliberately risking countless individuals to line their pockets," Paxton, from the Republican party, said.

The manufacturer stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the welfare of women and children in America."

On its official site, Kenvue also stated it had "continuously evaluated the relevant science and there is insufficient valid information that demonstrates a verified association between using acetaminophen and autism spectrum disorder."

Groups representing doctors and medical practitioners agree.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for expectant mothers to address discomfort and fever, which can create serious health risks if left untreated.

"In multiple decades of research on the use of paracetamol in gestation, no reliable research has conclusively proven that the consumption of acetaminophen in any period of pregnancy leads to neurological conditions in offspring," the association commented.

The lawsuit mentions current declarations from the previous government in claiming the medication is potentially dangerous.

In recent weeks, Trump caused concern from health experts when he instructed women during pregnancy to "struggle intensely" not to take acetaminophen when ill.

The FDA then released a statement that doctors should consider limiting the usage of Tylenol, while also declaring that "a proven link" between the medication and autism in minors has not been established.

The Health Department head Kennedy, who manages the Food and Drug Administration, had vowed in April to undertake "extensive scientific investigation" that would identify the source of autism spectrum disorder in a matter of months.

But specialists advised that discovering a sole reason of autism spectrum disorder - considered by experts to be the outcome of a intricate combination of genetic and environmental factors - would prove challenging.

Autism is a category of enduring cognitive variation and condition that impacts how persons perceive and interact with the environment, and is identified using doctors' observations.

In his legal document, Paxton - a Trump ally who is running for the Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism.

This legal action attempts to require the corporations "destroy any promotional materials" that asserts acetaminophen is safe for pregnant women.

The Texas lawsuit echoes the grievances of a assembly of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of acetaminophen in 2022.

The court threw out the case, declaring research from the parents' expert witnesses was inconclusive.